MedTrace Logo

Acceptability of a Multiple Micronutrient-Fortified Lipid-Based Nutrient Supplement for Children Under Two in Cambodia

NCT02257437 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2016-09-15

No results posted yet for this study

Summary

The purpose of this trial is to evaluate the acceptability of the LNS to women and their children aged 12-17 months in comparison to Corn Soy Blend++, and Sprinkles added to borbor (white rice porridge, which is the traditional weaning food in Cambodia). Acceptability will be assessed through a sensory test for caregivers, and by measuring children's consumption.

Conditions

  • Child Malnutrition

Interventions

DIETARY_SUPPLEMENT

LNS snack

Compact, paste-filled wafer snack containing fish, rice, soy, mungbeans, oil, sugar and multiple micronutrients.

DIETARY_SUPPLEMENT

Corn-soy blend ++ (CSB++)

Blended flour containing soy, corn, milk powder, oil, sugar and multiple micronutrients.

DIETARY_SUPPLEMENT

Sprinkles

Multiple micronutrient powder packaged in sachet added to borbor (traditional white rice porridge).

DIETARY_SUPPLEMENT

LNS + borbor

Compact, paste-filled wafer snack containing fish, rice, soy, mungbeans, oil, sugar and multiple micronutrients added to borbor (traditional white rice porridge).

Sponsors & Collaborators

  • UNICEF

    collaborator OTHER

  • Department of Fisheries Post-harvest Technologies and Quality Control

    collaborator OTHER

  • Institut de Recherche pour le Developpement, Cambodia

    lead OTHER_GOV

Principal Investigators

  • Frank T Wieringa, MD, PhD · IRD

  • Bindi Borg, PhD student · University of Sydney

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
9 Months
Max Age
23 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • Cambodia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02257437 on ClinicalTrials.gov